封面
市场调查报告书
商品编码
1638818

唇部注射市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Lip Injection Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球唇部注射市场价值为31.8 亿美元,预计2024 年至2032 年复合年增长率为7.3%。更美丽的嘴唇。这种增强是透过手术和非手术技术实现的,其中真皮填充剂是一种流行的选择。社会对身体美学和美容标准的重视推动了市场的成长,特别是嘴唇丰满的趋势,这增加了对唇部增强治疗的需求。

支持这种增长的几个关键因素包括医疗旅游的兴起、整容手术的需求以及社交媒体和名人文化的影响。此外,人口老化的不断加剧以及人们对丰唇益处的认识不断提高,也正在推动消费者的兴趣。重要的市场贡献因素包括关键产品的发布、製造商的高度集中以及策略合作伙伴关係和收购,这些共同推动了产业扩张。

唇部注射市场按产品类型细分,包括胶原蛋白填充剂、透明质酸填充剂、聚L-乳酸填充剂、羟基磷灰石钙填充剂等。 2023 年,透明质酸填充剂领域产生了11.9 亿美元的收入,预计2024 年至2032 年将以8.6% 的复合年增长率增长。酸填充剂提供了安全、有效的无需长时间停机即可打造更饱满、更清晰的双唇的解决方案。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 31.8 亿美元
预测值 59.5 亿美元
复合年增长率 7.3%

市场也可以根据手术类型分为暂时性增强和永久性增强。到 2023 年,临时手术约占市场份额的 64%,预计整个预测期内的复合年增长率为 7.1%。同时,永久选择权预计将以 7.7% 的复合年增长率成长。临时增强的吸引力在于其可逆性,使消费者能够尝试不同的美学趋势,而无需做出永久性的改变。

从地区来看,北美领先市场,2023 年美国市场价值将达到10 亿美元,预计2024 年至2032 年复合年增长率为8.7%。见效的青睐。美容水疗中心和诊所数量的增加也使这些服务更容易获得,进一步刺激了需求。技术进步不断提高治疗的安全性和有效性,巩固了唇部注射在该地区的吸引力。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
    • 影响价值链的因素
    • 利润率分析
    • 干扰
    • 未来展望
    • 製造商
    • 经销商
  • 供应商格局
  • 利润率分析
  • 重要新闻和倡议
  • 监管环境
  • 衝击力
    • 成长动力
      • 对整容手术和皮肤治疗的认识不断提高
      • 社群媒体和名人文化的影响力不断上升
    • 产业陷阱与挑战
      • 监管挑战
      • 不断变化的消费者偏好和道德问题
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:依产品类型,2021-2032

  • 主要趋势
  • 透明质酸填充剂
  • 胶原蛋白填充剂
  • 羟基磷灰石钙填料
  • 聚-L-乳酸填料
  • 其他(聚甲基丙烯酸甲酯或PMMA填料等)

第 6 章:市场估计与预测:按类型,2021-2032 年

  • 主要趋势
  • 暂时的
  • 永恆的

第 7 章:市场估计与预测:按应用划分,2021-2032 年

  • 主要趋势
  • 美容增强
  • 重建手术

第 8 章:市场估计与预测:依最终用途,2021-2032 年

  • 主要趋势
  • 专科和皮肤科诊所
  • 医院和诊所
  • 美容院/水疗中心
  • 其他(外科中心等)

第 9 章:市场估计与预测:依配销通路划分,2021-2032 年

  • 主要趋势
  • 在线的
  • 离线
    • 药局
    • 零售药局
    • 其他的

第 10 章:市场估计与预测:按地区划分,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非

第 11 章:公司简介

  • Allergan
  • Bioplus
  • Galderma
  • Hugel
  • Hyamed
  • Ipsen
  • Medtox
  • Merz Pharma
  • Revance Aesthetics
  • Sinclair
  • Suneva Medical
  • Vivacy
简介目录
Product Code: 12114

The Global Lip Injection Market, valued at USD 3.18 billion in 2023, is projected to expand at a CAGR of 7.3% from 2024 to 2032. Lip injections, also known as lip augmentation procedures, enhance lip size and shape, providing a fuller, more appealing appearance. This enhancement is achieved through both surgical and non-surgical techniques, with dermal fillers being a popular choice. Market growth is being fueled by society's emphasis on physical aesthetics and beauty standards, notably the trend toward fuller lips, which has increased demand for lip enhancement treatments.

Several key factors support this growth, including the rise in medical tourism, the demand for cosmetic surgeries, and the influence of social media and celebrity culture. Additionally, a growing aging population and increased awareness of the benefits of lip augmentation are driving consumer interest. Significant market contributors include key product launches, a high concentration of manufacturers, and strategic partnerships and acquisitions, which collectively advance industry expansion.

The lip injection market is segmented by product type, including collagen fillers, hyaluronic acid fillers, poly-L-lactic acid fillers, calcium hydroxyapatite fillers, and others. In 2023, the hyaluronic acid fillers segment generated USD 1.19 billion in revenue and is forecasted to grow at an 8.6% CAGR from 2024 to 2032. This growth highlights a preference for non-surgical cosmetic options, as hyaluronic acid fillers offer a safe, effective solution for fuller, more defined lips without extensive downtime.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$3.18 Billion
Forecast Value$5.95 Billion
CAGR7.3%

The market can also be divided by procedure type into temporary and permanent augmentations. Temporary procedures represented approximately 64% of the market share in 2023, with a projected CAGR of 7.1% through the forecast period. Meanwhile, permanent options are anticipated to grow at a 7.7% CAGR. The appeal of temporary augmentations lies in their reversibility, allowing consumers to try different aesthetic trends without committing to permanent changes.

Regionally, North America leads the market, with the U.S. valued at USD 1 billion in 2023 and expected to grow at a CAGR of 8.7% from 2024 to 2032. In the U.S., non-surgical cosmetic procedures like lip injections are increasingly favored for quick recovery times and effective results. The rising number of aesthetic spas and clinics has also made these services more accessible, further boosting demand. Technological advancements continue to enhance treatment safety and efficacy, solidifying the appeal of lip injections in this region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Rising awareness for cosmetic surgeries & skin treatments
      • 3.6.1.2 Rising influence of social media and celebrity culture
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Regulatory challenges
      • 3.6.2.2 Changing consumer preferences & ethical concerns
  • 3.7 Growth potential analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2032 (USD Billion) (Thousand Units)

  • 5.1 Key trends
  • 5.2 Hyaluronic acid fillers
  • 5.3 Collagen fillers
  • 5.4 Calcium hydroxyapatite fillers
  • 5.5 Poly-L-lactic acid fillers
  • 5.6 Others (polymethylmethacrylate or PMMA Fillers, etc.)

Chapter 6 Market Estimates & Forecast, By Type, 2021-2032 (USD Billion) (Thousand Units)

  • 6.1 Key trends
  • 6.2 Temporary
  • 6.3 Permanent

Chapter 7 Market Estimates & Forecast, By Application, 2021-2032 (USD Billion) (Thousand Units)

  • 7.1 Key trends
  • 7.2 Cosmetic enhancement
  • 7.3 Reconstructive procedures

Chapter 8 Market Estimates & Forecast, By End Use, 2021-2032 (USD Billion) (Thousand Units)

  • 8.1 Key trends
  • 8.2 Specialty & dermatology clinics
  • 8.3 Hospitals & clinics
  • 8.4 Beauty Salons/Spa centers
  • 8.5 Others (Surgical centers, etc.)

Chapter 9 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Billion) (Thousand Units)

  • 9.1 Key trends
  • 9.2 Online
  • 9.3 Offline
    • 9.3.1 Drug stores
    • 9.3.2 Retail pharmacy stores
    • 9.3.3 Others

Chapter 10 Market Estimates & Forecast, By Region, 2021-2032 (USD Billion) (Thousand Units)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 UK
    • 10.3.2 Germany
    • 10.3.3 France
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Russia
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 India
    • 10.4.3 Japan
    • 10.4.4 South Korea
    • 10.4.5 Australia
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
  • 10.6 MEA
    • 10.6.1 UAE
    • 10.6.2 Saudi Arabia
    • 10.6.3 South Africa

Chapter 11 Company Profiles

  • 11.1 Allergan
  • 11.2 Bioplus
  • 11.3 Galderma
  • 11.4 Hugel
  • 11.5 Hyamed
  • 11.6 Ipsen
  • 11.7 Medtox
  • 11.8 Merz Pharma
  • 11.9 Revance Aesthetics
  • 11.10 Sinclair
  • 11.11 Suneva Medical
  • 11.12 Vivacy